Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olaparib + Bevacizumab Maintenance in Advanced Ovarian Cancer
NCT02477644Phase 3Completed
- Sponsor
- ARCAGY
- Start
- May 2015
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of olaparib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by ARCAGY. Started May 2015; status: completed.
02
Drugs
olaparib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT02477644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02477644.